Catalog Number 03-2794-0 |
Device Problem
Fluid/Blood Leak (1250)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 12/08/2017 |
Event Type
malfunction
|
Manufacturer Narrative
|
The plant investigation is in process.A supplemental medwatch report will be submitted upon completion of this activity.
|
|
Event Description
|
A nurse manager at a user facility reported that that there was blood leaking around the blue circle of the bloodline venous sample port immediately after the initiation of a patient's hemodialysis (hd) treatment.The estimated blood loss (ebl) was reported to be 10ml.The treatment was interrupted and the patient was set-up with new supplies.The patient was able to complete treatment with no serious injury or impact.No medical intervention was required.The device was stated to be available to be returned to the manufacturer for evaluation.
|
|
Manufacturer Narrative
|
The complaint device was returned to the manufacturer for physical evaluation.A visual inspection was performed on the returned bloodline sample and no defects or damages were observed.There were no issues found in the venous injection site.All bonds from the arterial and venous lines were reviewed and found to have been properly assembled.The sample was tested using a 2008t hemodialysis machine for simulated use.During the simulated use test, there were no observations of a leak or air bubbles and no level variations of the venous or arterial drip chambers.There were no observed leaks at the venous injection site.The device worked as intended with no noted abnormalities and no defects identified.The investigation into the cause of the reported problem was not able to confirm the failure mode.The reported injection site blood leak was not able to be duplicated.Therefore, the complaint has been deemed unconfirmed.
|
|
Event Description
|
Follow-up information from the nurse manager revealed that there was blood leaking around the blue circle of the bloodline venous sample port immediately after the initiation of a patient's hemodialysis (hd) treatment.The location of the leak was clarified to have occurred at the blue injection site port on the venous bloodline.
|
|
Manufacturer Narrative
|
Plant investigation: although it was originally stated that the device was available to be returned to the manufacturer for analysis, no sample has been received to date.Therefore, the reported complaint was not confirmed as the complaint device was not available for manufacturer evaluation.As such, a definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.A records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.In addition, the dhr review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.A review of the dhr did not reveal a probable cause for the customer complaint.
|
|
Search Alerts/Recalls
|